0756 GMT - Roche delivered solid results in line with expectations but its diagnostics' profitability disappoints, Vontobel analyst Stefan Schneider says in a note. The Swiss pharma giant's core EBIT of its diagnostics unit missed Vontobel's estimates by 10.5% which surprises as only 1Q was still affected by the pandemic washout, the analyst says. Its 2025 guidance is conservative, unchanged under the new management, he adds. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
January 30, 2025 02:56 ET (07:56 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.